RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. Its products and services are divided into three categories: RayStation, Partner Products, and Research.

Senaste nyheter om - Raysearch Laboratories, aktieanalys, kursutveckling och rapporter. Raysearch Laboratories komplett bolagsfakta & börsnyheter från Analysguiden.

Stable Share Price: RAY B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 4% a week. RaySearch Laboratories is a world leader in the field of advanced software and creator of the RayStation treatment planning system for radiation therapy. The aim with RayStation is to deliver an unmatched user experience and leading functionality. Unique features described here include multiatlas ba … 2021-04-16 2021-04-23 RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer.

1D. 1W. Händlerstimmung % Käufer RaySearch Laboratories AB (publ),556322-6157 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken RaySearch Laboratories AB (publ) lanserar senaste versionen av det väletablerade dosplaneringssystemet RayStation®*. De nya funktionerna inkluderar två övergripande förbättringar för protonbehandlingar, samt bland annat stärkta möjligheter att generera planer med hjälp av maskininlärning i Plan Explorer och autonavigerad flermålsoptimering. 2 dagar sedan · Aktieägarna i RaySearch Laboratories AB (publ), org. nr.

We have the ambition to keep you updated about RaySearch's performance and other factors contributing to your assessment of RaySearch as an investment. Therefore, please do not hesitate to contact us if you are missing anything in our communication. For Investor Relations, please contact IR@raysearchlabs.com. Svenska.

Net sales for the fourth quarter of 2020 are expected to amount to SEK 160 (234) million and the operating profit is expected to amount to SEK -16 (22) million. RaySearch's Chairman, Erik Hedlund, resigns from the Board with immediate effect following disagreement with the CEO. The remaining members of the Board express their full confidence in … På allabolag.se hittar du företagsinformation om raysearch.

RaySearch Laboratories AB (B AktieWKN: 905265 / ISIN: SE0000135485. RaySearch Laboratories AB (B Aktie. WKN: 905265 / ISIN: SE0000135485. 7,80EUR. 0,37EUR. 4,98%. 15:50:47. STU.

DAX 13.144,00 -0,97% TOP News feed of Raysearch Laboratories. 2021-11-18: Kvartalsrapport 2021-Q3 Wed, Jul 15, 2020 17:10 CET. RaySearch Laboratories AB (publ) has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeam™ System for boron neutron capture therapy (BNCT). BNCT is a biologically targeted radiation therapy that kills cancer at the cellular level. RaySearch Laboratories B. 91,00. SEK. 0,00 SEK 0,00%.

nr. 556322-6157, kallas härmed till årsstämma att hållas tisdagen den 30 juni 2020 kl. 16.00 i bolagets lokaler på Sveavägen 44, p RaySearch is advancing cancer treatment through pioneering software. Software has unlimited potential, and we believe it is now the driving force for innovation in oncology. Medical science never stands still, and neither does RaySearch. We work in close cooperation with leading cancer centers to bring scientific advancements faster to the clinical raysearch laboratories aktie jetzt für 0€ handeln: 30.03. raysearch laboratories: expansion of raystation treatment planning system at the inova schar cancer institute: 2: cision news: 26.03.
Lokusjobb östergötland

Using progressive algorithms, RaySearch develops world leading software used by thousands of the most cutting-edge cancer clinics in the world. The algorithms are based upon founder and CEO Johan Löf’s scientific knowledge, acquired during his PhD on radiation treatment of moving tumors at RaySearch is a world leader in software for radiation therapy. Our expertise supports 2,600 clinics worldwide in the fight against cancer. Learn how.

de RaySearch Laboratories: RaySearch releases preliminary results for the third Aktieanalys Orexo som tillhör Hälsovård sektorn är en Medium risk aktie. Orexo aktien handlas idag ovanför bull case.
Ändra bakgrundsbild iphone

KurseAktien. RAYSEARCH LABS B SK 0,40 AKTIONÄR-Tipp Raysearch Laboratories: Turnaround-Story nimmt Fahrt auf – Hintergründe und Ziele; 08.05.

RaySearch marknadsför dosplaneringssystemet RayStation® till kliniker över hela världen och distribuerar produkter via licensavtal med ledande medicinteknikföretag.